Press release
The companion diagnostics development services market, is anticipated to grow at a CAGR of over 10%, till 2035, claims Roots Analysis
Companion Diagnostics market
The growing pipeline of patient-centric targeted therapies has led to a surge in demand for companion diagnostics; these tests are known to improve the success rates of late-stage trials by almost three-fold. The development and approval of these FDA classified high-risk devices requires multidisciplinary expertise and an established network of R&D and production facilities that can be accessed through service providers.
To order this 660+ page report, which features 190+ figures and 260+ tables, please visit https://www.rootsanalysis.com/reports/view_document/companion-diagnostics-services/297.html
Key Market Insights
Over 150 companies claim to offer companion diagnostics development services, globally
Nearly 60% of the aforementioned players are based in North America, followed by the players located in Europe (30%). Further, this segment of the industry is dominated by the presence of mid-sized players (51-200 employees), which represent 40% of the total service providers.
Nearly 15% players claim to act as one-stop shops, offering services, ranging from biomarker discovery and development to manufacturing and commercialization
Most of the service providers (127) provide assay development services, followed by companies (124) offering services for biomarker discovery / identification. Further, NGS is the most popular technique, employed by over 100 service providers.
Over 90 companies are actively involved in companion diagnostics development
Nearly 91% of the total tests can detect mutations in a single biomarker. Amongst these, ErbB gene family (HER-2 and EGFR genes), PD-L1 genes, RAS gene family (KRAS and NRAS genes), BRCA gene family (BRCA1 and BRCA2) and BRAF emerged as the key genes which are assessed by majority of the companion diagnostics.
Partnership activity in this domain has increased at a CAGR of ~25%, between 2017 and 2021
Mergers and acquisitions, product development agreements and product development and commercialization agreements account for more than 60% of the total number of deals inked during the given time period. It is worth highlighting that nearly 25% of the total number of deals were signed in 2021. Further, the maximum number (177) of partnerships have been inked for companion diagnostics being developed for the treatment of oncological disorders.
North America is expected to capture ~60% share in the companion diagnostics services market by 2035
Owing to the high costs associated with the clinical validation of companion diagnostics, a significant proportion (~46%) of service revenues is generated from this step, in 2035. In terms of analytical technique used, service contracts involving NGS are anticipated to contribute to more than 35% of the total service revenues generated in 2035. Further, close to 90% of the total service revenues, in 2035, are generated from companion diagnostics development projects for cancer indications.
To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/companion-diagnostics-services/request-sample.html
Key Questions Answered
* Who are the leading players offering services for the development of companion diagnostics?
* Which are the key geographies where companion diagnostics development service providers are located?
* Which analytical techniques are used by the service providers engaged in companion diagnostics services market?
* Who are the leading companion diagnostics developers?
* Which biomarkers are most commonly targeted by the marketed products / investigational programs?
* Which partnership models are commonly adopted by stakeholders offering companion diagnostics services?
* Which drug developers are most likely to partner with the service providers to seek their expertise?
* What are the key value drivers of the merger and acquisition activity within companion diagnostics development services market?
* Which biomarker-focused targeted drugs developed by big pharmaceutical companies are likely to be administered with companion diagnostics?
* How is the current and future opportunity likely to be distributed across companion diagnostics market?
The financial opportunity within the companion diagnostics services market has been analyzed across the following segments:
* Type of Service Offered
- Feasibility Studies
- Assay Development
- Analytical Validation
- Clinical Validation
- Manufacturing
* Type of Technique Used
- NGS
- PCR
- ICH / ISH
- Liquid Biopsy
- Others
* Therapeutic Areas
- Oncological
- Non-oncological
* Key Geographical Regions
- North America
- Europe
- Asia-Pacific and Rest of the World
The report also features detailed transcripts of discussions (in reverse chronological order) held with the following experts:
* Mike Klein (Chief Executive Officer, Genomenon)
* Mark Kiel (Founder and Chief Scientific Officer, Genomenon)
* Candace Chapman (Vice President of Marketing, Genomenon)
* Anton Iliuk (President and Chief Technology Officer, Tymora Analytical Operations)
* Paul Kortschak (Former Senior Vice President, Novodiax)
* Pablo Ortiz (Chief Executive officer, OWL Metabolomics)
* Lawrence Weiss (Former Chief Scientific Officer, NeoGenomics Laboratories)
The research includes detailed profiles of key players (listed below), each profile features an overview of the company, its financial information (if available), drug portfolio, details on recent developments, and an informed future outlook.
* Almac Diagnostic Services
* BGI Genomics
* Biocartis
* Cerba Research
* Geneuity Clinical Research Services
* Interpace Biosciences
* Labcorp (formerly known as Covance)
* MEDICAL & BIOLOGICAL LABORATORIES (MBL)
* MEDx (Suzhou) Translational Medicine (formerly known as QIAGEN (Suzhou) Translational Medicine)
* MLM Medical Labs
* Novogene
* Q2 Solutions
* Quest Diagnostics
* ResearchDx
For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/companion-diagnostics-services/297.html or email sales@rootsanalysis.com
You may also be interested in the following titles:
- Flow Cytometry Services Market, 2022-2035
- Precision Medicine Software Developers Market, 2021-2031
- Next Generation Sequencing (NGS) Kits Market, 2022-2035
- Cell and Gene Therapy Bioassay Services Market, 2021-2031
- Point-of-Care Diagnostics Market, 2020-2025
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com
Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis
Medium: https://medium.com/@RootsAnalysis
Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/
Quora: https://rootsanalysisinsights.quora.com/
We specialise in analysing areas which have lacked quality research so far or require more focussed understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The companion diagnostics development services market, is anticipated to grow at a CAGR of over 10%, till 2035, claims Roots Analysis here
News-ID: 2689980 • Views: …
More Releases from Roots Analysis
Carbon footprint management market is Set to Soar to USD 55.9 Billion by 2035
Carbon footprint refers to the measurement of greenhouse gas emissions, expressed in carbon dioxide equivalent. It is released into the atmosphere either directly or indirectly through various activities, processes, or products. These emissions originate from diverse sources, including energy consumption, manufacturing processes, transportation networks, and waste management strategies.
The global carbon footprint management market, valued at USD 12.2 billion in 2024, is expected to reach USD 13.5 billion in 2025…
Gene switches have garnered significant attention from drug developers owing to …
The global gene switch market size is estimated to grow from USD 795 million in 2025 to USD 2,478 million by 2035, representing a CAGR of 12.03% during the forecast period till 2035.
Driven by numerous developmental breakthroughs and encouraging study results demonstrating the vast potential of adoptive cell therapies (ACT), including CAR-T cell therapies, TCR therapies, TILs and natural killer cell therapies, in the treatment of various complex disorders, this…
Antibody Discovery Market Set to Soar to $6.6 Billion by 2035
Antibodies, also known as immunoglobulins, are Y-shaped glycoproteins that are produced by the immune system in response to foreign molecules (antigens) that enter the body. The term antigen refers to any substance that is capable of inducing an immune response, encompassing a diverse range of entities, including viruses, fungi, bacteria, proteins on the surface of cells, and non-living substances, such as toxins, chemicals and foreign particles.
The global antibody discovery…
Biopsy is defined as a procedure of removing or extracting tissue from the body …
The global virtual biopsy market, valued at USD 0.73 billion in 2024, is projected to reach USD 0.78 billion in 2025 and USD 3.02 billion by 2035, representing a CAGR of 14.47% during the forecast period.
This procedure plays a crucial role in the diagnosis or monitoring of certain medical conditions such as inflammatory disorders, immune disorders, oncological conditions, and several infections. By analyzing the cellular composition of the extracted tissue,…
More Releases for Mark
MARK WAHLBERG INSTANT EARWORMS!
A jingle for Mark Wahlberg and Wahlburgers ( link below ). Host and enthusiastic Wahlburgers fan DeeDee from CRAZY JOURNEYS with DeeDee is putting out an open invitation to Mark Wahlberg himself - to join her for a fun, fresh photo retake at one of his legendary Wahlburgers locations.
Why? Because every great journey deserves a great snapshot- and the magic of an awesome burger.
DeeDee, whose content on YouTube has…
INTERVIEW: MARK JAMES SCOTT
I sat down with Brand Consultant, Designer & Creative Director Mark James Scott who is making an Impact in the Hip Hop World, in both the UK and the US. We talked working with Artists from The Game and Music Mogul Diddy, to his own Music and more..
BY SASHA JENKINS
WHAT SETS YOU APART FROM OTHERS IN YOUR FIELD?
I didn't study Design. I studied Psychology for 6 years and gained my Masters…
Impressionist landscape artist - Mark Briscoe
I am Mark Briscoe, Bristish artist well established in the field of Chinoiserie furniture decoration and restoration of antique lacquer. But the techniques for fine art easel painting in the wonderful manner of the old masters is something which I have been exploring in great earnest over the last two years as a long cherished desire. And while I cannot claim to have come anywhere near their heights, I have…
Mark de Clive-Lowe
On Thursday, May 3rd, 2012 internationally known musician Mark de Clive-Lowe (MdCL), will take the stage at The Beehive, located in Boston, MA, for a special performance of his revolutionary sound. Be there from 9:30PM to 1:00AM as MdCL plays impromptu remixes created from scratch, on the spot using drum machines, keyboards and special effects. He will start with a jazz-oriented set and crank up the intensity with his signature…
Trade Mark Act
Neoinfo Solutions Pvt. LTD is an IT based company with its main office located in Jaipur(rajasthan). Our expertise lies in the domain of Website Designing development portal development,maintenance software consulting, designing development , implimentation, training and maitenance.In the journey of achieving our combined business and social goals we have kept in mind and have always strictly followed all our data security policies to ensure that all informations of our clients…
Trade mark Act
Neoinfo Solutions Pvt. LTD is an IT based company with its main office located in Jaipur(rajasthan). Our expertise lies in the domain of Website Designing development portal development,maintenance software consulting, designing development , implimentation, training and maitenance.In the journey of achieving our combined business and social goals we have kept in mind and have always strictly followed all our data security policies to ensure that all informations of our clients…
